No profile data available.
Anika Therapeutics, Inc. (ANIK) is a healthcare company in the bone and joint treatment equipment industry, based in Bedford, United States, with about 235 full-time employees.
It reported revenue of $112.82 million for fiscal year 2025, down 5.9% from fiscal year 2024, and net income of -$10.88 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $29.61 million, up 13.2% from a year before. United States was its largest region in fiscal year 2025, with 62% of revenue. Its market capitalization was $262.04 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.
Anika Therapeutics reported $112.82 million in revenue for fiscal year 2025, down 5.9% from $119.91 million in fiscal year 2024. In Q1 2026 revenue was $29.61 million.
United States: 62% of revenue by region in fiscal year 2025, followed by Europe (20%).
$262.04 million as of October 9, 2026.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include OrthoPediatrics Corp. (KIDS), Carlsmed, Inc. (CARL), Orthofix Medical Inc. (OFIX), Treace Medical Concepts, Inc. (TMCI).